Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

medtech

  • Home
  •  
  • medtech



  • Most Read
  • Latest Comments
  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • PainChek locks in performance data for FDA submission, aiming to be  first pain assessment app approved in US
    PainChek locks in performance data for FDA submission, aiming to be first pain assessment app approved in US
    • News

  • HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    HeraMED eyes TGA reclassification to restore HeraBEAT device for at-home use
    • News

  • dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    dorsaVi secures $110k in contracts across mining, healthcare, and shipping sectors
    • News

  • Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    Compumedic hits record medtech diagnostics revenue with growth in US and China being targeted
    • News

  • TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    TGA approves Control Bionic’s autonomous wheelchair for commercial sales after NDIS delays
    • News

  • Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first
    • News

    Labour shortages and cost inflation slug Integral Diagnostics, hopes for better second half than first

    Australia’s labour shortage struggles are far from over, continuing to impact companies like diagnostic imaging services provider Integral Diagnostics (ASX: IDX). This impact was reflected in its mixed results for the first half of FY24.  Integral Diagnostics is an Australia and New Zealand-based medical diagnostics company offering radiology services—from X-rays and CT scans to ultrasounds,

    Read More
    Public
  • They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs
    • News

    They see me rollin, they lovin: Control Bionics receives $577k grant from the ALS association to develop self-driving wheelchairs

    If you thought only cars could be autonomous (hey, Tesla), think again. Medical device company Control Bionics (ASX: CBL) has wheeled the technology into autonomous wheelchairs, ensuring people with Amyotrophic Lateral Sclerosis (ALS)—a motor neuron disease—live a better, “freer” life.  In support of that, the Company’s wholly-owned US subsidiary has secured a research grant of

    Read More
    Public
  • Nova Eye Medical reports surge in USA sales despite Medicare reimbursement uncertainty
    • News

    Nova Eye Medical reports surge in USA sales despite Medicare reimbursement uncertainty

    Aussie MedTech company Nova Eye Medical (ASX: EYE) has kicked off the new year with good news for investors, recording an impressive $7.6 million in sales in the US for its glaucoma surgical devices during the six months concluding on December 31, 2023 (unaudited).  This represents a remarkable 65% growth compared to the previous corresponding

    Read More
    Public
  • Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection
    • News

    Proteomics signs deal with Omics Global Solutions to provide Chile with early diabetic kidney disease detection

    In Chile, one in eight adults have diabetes. The number of people with the condition there has risen almost 50% in the past ten years. By 2030, the healthcare spending on diabetes in Chile is set to surpass $4 billion. Chile’s healthcare needs demand companies like medical tech company Proteomics (ASX: PIQ) that emphasise early

    Read More
    Public
  • HeraMED’s pregnancy monitoring device expands reach to rural GPs and customers via Telstra Health partnership
    • News

    HeraMED’s pregnancy monitoring device expands reach to rural GPs and customers via Telstra Health partnership

    Making maternity care more accessible to all expectant parents including those in regional and rural Australians, HeraMED (ASX: HMD) has been promoting at-home pregnancy management using its digital monitoring device HeraCARE. Now the Company has levelled up its strategic shift for the device by securing a new Partner Agreement with Telstra Health, expanding its customer

    Read More
    Public
  • MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract
    • News

    MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract

    Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone.  For countries like Estonia and the US, it entailed boosting telehealth services. For

    Read More
    Public
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.